Use of androgen deprivation therapy in prostate cancer: indications and prevalence
Roisín M. Connolly(Johns Hopkins University), Emmanuel S. Antonarakis(University of Minnesota)
Cited by 63
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
|Journal of Clinical Oncology|2019|364